A detailed history of Vermillion Wealth Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Vermillion Wealth Management, Inc. holds 2,984 shares of LLY stock, worth $2.39 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
2,984
Previous 2,822 5.74%
Holding current value
$2.39 Million
Previous $2.2 Billion 3.49%
% of portfolio
0.62%
Previous 1.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$625.65 - $812.69 $101,355 - $131,655
162 Added 5.74%
2,984 $2.28 Billion
Q2 2025

Jul 17, 2025

SELL
$713.71 - $898.95 $1.78 Million - $2.24 Million
-2,494 Reduced 46.91%
2,822 $2.2 Billion
Q1 2025

Apr 28, 2025

BUY
$725.72 - $929.72 $2,177 - $2,789
3 Added 0.06%
5,316 $4.39 Billion
Q4 2024

Feb 21, 2025

BUY
$727.2 - $932.06 $3.86 Million - $4.95 Million
5,313 New
5,313 $4.1 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vermillion Wealth Management, Inc. Portfolio

Follow Vermillion Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vermillion Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vermillion Wealth Management, Inc. with notifications on news.